Laboratorio Farmaceutico Erfo Past Earnings Performance
Past criteria checks 0/6
Laboratorio Farmaceutico Erfo's earnings have been declining at an average annual rate of -12.8%, while the Personal Products industry saw earnings growing at 6% annually. Revenues have been growing at an average rate of 5.4% per year. Laboratorio Farmaceutico Erfo's return on equity is 8.7%, and it has net margins of 13.3%.
Key information
-12.8%
Earnings growth rate
-27.8%
EPS growth rate
| Personal Products Industry Growth | 13.6% |
| Revenue growth rate | 5.4% |
| Return on equity | 8.7% |
| Net Margin | 13.3% |
| Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Laboratorio Farmaceutico Erfo makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 23 | 5 | 1 | 1 | 0 |
| 31 Mar 23 | 5 | 1 | 1 | 0 |
| 31 Dec 22 | 5 | 1 | 1 | 0 |
| 30 Sep 22 | 5 | 1 | 1 | 0 |
| 30 Jun 22 | 5 | 1 | 1 | 0 |
| 31 Mar 22 | 5 | 1 | 1 | 0 |
| 31 Dec 21 | 5 | 1 | 1 | 0 |
| 31 Dec 20 | 4 | 1 | 1 | 0 |
| 31 Dec 19 | 5 | 1 | 1 | 0 |
| 31 Dec 18 | 4 | 1 | 1 | 0 |
Quality Earnings: ERFO has a high level of non-cash earnings.
Growing Profit Margin: ERFO's current net profit margins (13.3%) are lower than last year (19.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ERFO's earnings have declined by 12.8% per year over the past 5 years.
Accelerating Growth: ERFO's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: ERFO had negative earnings growth (-27.8%) over the past year, making it difficult to compare to the Personal Products industry average (16.6%).
Return on Equity
High ROE: ERFO's Return on Equity (8.7%) is considered low.